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Abstract
Background: Central line-associated bloodstream infections (CLABSI) are a cause of increased morbidity and
mortality, and are largely preventable. We documented attitudes and practices in intensive care units (ICUs) in 2015
in order to assess compliance with CLABSI prevention guidelines.
Methods: Between June and October 2015, an online questionnaire was made available to medical doctors and
nurses working in ICUs worldwide. We investigated practices related to central line (CL) insertion, maintenance and
measurement of CLABSI-related data following the SHEA guidelines as a standard. We computed weighted
estimates for high, middle and low-income countries using country population as a weight. Only countries
providing at least 10 complete responses were included in these estimates.
Results: Ninety five countries provided 3407 individual responses; no low income, 14 middle income (MIC) and 27
high income (HIC) countries provided 10 or more responses. Of the total respondents, 80% (MIC, SE = 1.5) and
81% (HIC, SE = 1.0) reported availability of written clinical guidelines for CLABSI prevention in their ICU; 23%
(MIC,SE = 1.7) and 62% (HIC,SE = 1.4) reported compliance to the following (combined) recommendations for CL
insertion: hand hygiene, full barrier precaution, chlorhexidine >0.5%, no topic or systemic antimicrobial prophylaxis;
60% (MIC,SE = 2.0) and 73% (HIC,SE = 1.2) reported daily assessment for the need of a central line. Most considered
CLABSI measurement key to quality improvement, however few were able to report their CLABSI rate. Heterogeneity
between countries was high and country specific results are made available.
Conclusions: This study has identified areas for improvement in CLABSI prevention practices linked to CL insertion and
maintenance. Priorities for intervention differ between countries.
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Background
Central line-associated bloodstream infections (CLABSI)
occurring in intensive care units (ICUs) are a cause of
increased morbidity and mortality, and are largely pre-
ventable [1–3]. CLABSI prevention requires evidence
based clinical practices on the one hand and monitoring
of these clinical interventions on the other hand.
Clinical practices can be classified in three categories,
(1) practices at central line (CL) insertion (such as
maximal barrier precautions, avoiding femoral vein if
possible); (2) practices during maintenance of a CL; and
(3) reduction of exposure to a CL (such as daily assess-
ment of the need for CL and timely removal of unneces-
sary CL) [4, 5]. Several studies in high income countries
have shown that adequate use of CLABSI prevention
measures can significantly reduce CLABSI rate [6–9].
Studies have also shown that elementary infection con-
trol measures may reduce the incidence of CLABSIs in
low and middle income countries significantly, amount-
ing to a reduction from 6.5 to 46.0 cases per 1000 CL
days to 2.4–12.4 cases per 1000 CL days [10–15]. Yet,
CLABSI rates reported in low and middle income coun-
tries, where resources are limited, are much higher than
CLABSI rates reported in high income countries [16].
Although evidence-based prevention practices for
CLABSI have been established, ensuring sustained ad-
herence to them is a challenge [16, 17]. For this reason,
measurement of outcomes and processes is an essential
component of any intervention aimed at improving
quality of care [5].
This study aimed to document, attitudes and practices
(clinical and measurement) regarding CLABSI preven-
tion in ICUs in low, middle and high income countries
in order to assess compliance with CLABSI prevention
guidelines, its measurement and identify priorities for
interventions.
Methods
Study setting and population
Our study population comprised of medical doctors and
nurses working in an ICU in the year 2015. The medical
doctor and nurse could work in the same ICU and more
than one reply was possible from one unit.
An ICU was defined as a unit meeting all of the fol-
lowing criteria: provides facilities for invasive mechanical
ventilation, and pump-controlled administration of infu-
sion, functions 24 h a day and 7 days a week, and there
is at least one doctor immediately available at all times
to deal with emergencies.
Questionnaire
An online questionnaire was developed and consisted of
five parts: 1) Characteristics of the respondent and ICU
setting, 2) Clinical practices for CL insertion, 3) Clinical
practices for CL maintenance, 4) Monitoring of out-
comes and processes and 5) Attitudes towards measure-
ment as a tool for improvement. We used as a reference
clinical practice guidelines published by the Society for
Healthcare Epidemiology of America (SHEA) [4]. We in-
cluded questions on the measurement of outcomes
(CLABSI rate and the ability to report selected indicators)
and measurement of processes such as compliance with
prevention practices, including hand hygiene, and the de-
vice utilization ratio (ratio of central-line days to patient-
days). Attitudes regarding the implementation of a data
collection system was measured using a 5 point-Likert
scale (1: strongly agree, 5: strongly disagree) [17, 18].
The questionnaire was developed and pretested in
English and translated into 9 languages (Spanish,
German, Portuguese, Italian, French, Dutch, Russian,
Mandarin and Japanese). Native speaker intensive care
doctors and/or infection control practitioners translated
the questionnaire. Each translation was independently
verified by a second native speaking physician. Participa-
tion was anonymous.
We used Limesurvey ® 2.0, an open source web survey
application, to collect the data [19].
Dissemination to target group
The questionnaire was available online from 10 June
2015 to 31 October 2015. It was endorsed by 5 inter-
national societies (the European Society of Intensive
Care Medicine (ESICM), the Society of Critical Care
Medicine (SCCM), the World Federation of Societies of
Intensive Care and Critical Medicine (WFSICCM), the
International Symposium on Intensive Care and
Emergency Medicine (ISICEM) and the Middle East
Critical Care Assembly (MCCA)), and one national
society (Japanese society of intensive care medicine
(JSCIM)). Endorsement implied mailing to members;
and/or posting on the website. We also identified and
contacted national ICU societies who advertised the
questionnaire on their website and pertaining congresses,
and developed mass mailings to all its members.
Sample size
No sample size or power calculations were conducted.
Data analysis
Descriptive statistics were used to summarize character-
istics of the study population Standard errors were cal-
culated by dividing the standard deviations of each
estimate by the square root of the sample size (n).
Based on the 2015 World Bank classification [20] we
categorized countries as low, middle and high- income.
We computed weighted estimates for middle and high-
income countries using total country population [20] as
the weight (to correct for contributing responses from
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each country) for those that provided at least 10 com-
pleted replies (arbitrary cut-off ).
Analyses were conducted using STATA 13 (svyset and
svy commands for survey data for weighted estimates).
Detailed country specific data are available as a
Additional file 1. Data are freely available and have been de-
posited in the Dryad Digital Repository: http://dx.doi.org/
10.5061/dryad.f7h12
Further use and exploitation of these data is
encouraged.
Results
Three thousand four hundred seven complete individual
responses were received from 95 countries. Weighted
estimates and standard errors for 14 middle and 27
high income countries are based on 3,250 responses
received from the 41 countries from which at least 10
completed replies were available. No low-income
countries provided 10 or more responses. Out of
3407 respondents, 157 (4%) came from 55 countries
for which less than 10 replies were given; 2414 (71%)
came from high income countries with at least 10
replies and 836 (25%) came from 14 middle income
countries with at least 10 replies. The distribution per
country is given in Table 1.
The characteristics of the respondents and their setting
by income country are presented in Table 2. 40% of the
respondents were nurses and 60% doctors. Of those who
reported availability of written guidelines for CLABSI pre-
vention, approximately 80% of the respondents in both
middle and high income countries reported that the
guidelines were last revised within the last 5 years.
CLABSI prevention clinical practices as reported by
ICU doctors and nurses are presented in Table 3. In
middle income countries, the use of chlorhexidine >0.5%
for skin preparation and full body drape during CL in-
sertion were less commonly implemented. Overall, only
23% and 62% of respondents from middle and high in-
come countries reported full compliance to the recom-
mended practices and avoided antimicrobial prophylaxis.
Measurements on compliance with CLABSI preven-
tion guidelines reported by ICU doctors and nurses are
Table 1 Number of respondents to the survey by country, 2015
Repliesa %b
High income countries
United States 401 17
Belgium 226 9
Spain 207 9
Russia 199 8
France 183 8
Japan 175 7
United Kingdom 135 6
Switzerland 120 5
Australia 110 5
Canada 103 4
Italy 82 3
Germany 62 3
Qatar 56 2
Portugal 53 2
Denmark 42 2
New Zealand 37 2
Argentina 37 1
Saudi Arabia 29 1
Netherlands 28 1
Norway 28 1
Greece 20 1
Poland 20 1
Sweden 15 1
Venezuela 12 0.5
Chile 14 0.5
Uruguay 10 0.5
Austria 10 0.5
Total responses of 27 high income countries with at
least 10 replies
2414 100
Middle income countries
China 379 45
India 130 16
Brazil 92 11
Jordan 38 5
Colombia 38 5
Mexico 24 3
Costa Rica 20 2
Lebanon 19 2
Sudan 19 2
South Africa 18 2
Turkey 18 2
Peru 16 2
Table 1 Number of respondents to the survey by country, 2015
(Continued)
Ecuador 13 2
Ukraine 12 1
Total responses of 14 Middle Income countries with at
least 10 replies
836 100
aReplies : total number of respondents per country providing a
complete questionnaire
b%: the proportion of total respondents per country
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presented in Table 4. The majority of respondents in
middle and high income countries say they monitor
regularly CLABSI rates, but only a minority can actu-
ally report those rates. The monitoring of process indi-
cators is lower in high compared to middle income
countries.
Attitudes of doctors and nurses towards the imple-
mentation of a measurement system of infection in
ICUs are presented in Table 5. The majority of re-
spondents in middle and high income countries have
a positive attitude towards measurement to stimulate
quality improvement.
Wide variations exist between countries. Less than half
of the respondents report availability of guidelines in
their ICU in Japan, (78/145, 45%) or Russia (90/199,
45%), but nearly all do in the US (383/401, 96%). In
France (35/183) and China (72/379) one in five respon-
dents (19%) report that femoral vein is used “always, or
most of the time” for CL insertion. In Belgium, 34%
(76/226) report daily assessment of need of CL while in
the UK this was 90% (121/135). Compliance with all
four recommended practices without the use of the 2
not-recommended during CL insertion was high in
Spain (176/207, 85%) and the US (323/401, 81%), but
low in Belgium (72/226, 32%), France (41/183, 22%),
Japan (52/175, 30%) and Russia (46/199, 23%). Complete
data can be found in the Additional file 1.
Discussion
Key results
This study represents, to our knowledge, the first inter-
national survey assessing CLABSI prevention practices
(clinical and measurement), and attitudes towards meas-
urement reported by ICU doctors and nurses. More than
3,000 provided complete responses, 40% of them were
nurses.
A majority of respondents (80%) report the existence
of CLABSI prevention guidelines in their ICU, demon-
strating a wide awareness of the CLABSI problem.
However several areas for improvement have been
identified. Combined compliance to 4 recommended
practices without the use of the 2 not-recommended
practices (such as antimicrobial prophylaxis) at CL
insertion was low particularly in middle income coun-
tries, the weakest point being in the utilization of
sterile drape to cover patients from head-to-toe and
the use of >0.5% chlorhexidine for skin preparation.
Only a minority of respondents still report the not
recommended femoral vein as the most used insertion
site in their ICU. During maintenance, dressings are
changed more often than recommended and assess-
ment of need of the CL is not always done on a daily
basis. Despite most of the respondents agreeing that
measurement is essential for improvement, and rou-
tinely counting CLABSI, only few were able to report
Table 2 Characteristics of the setting and respondent by income category in 2015
Middle income countries
(14 countries)
High income countries
(27 countries)
N = 836 SE* N = 2,414 SE*
Setting
Admissions per year in their ICU (mean) 1,024 59 1,123 36
N beds in ICU (mean) 22 0.8 19 0.5
Type of Hospital (University) (%) 65 2.0 59 1.5
Written guidelines for CLABSI prevention (answer yes) (%) 80 1.5 81 1.0
These guidelines include.... (%)
Indications for central-line 70 1.9 56 1.4
Process of insertion for central-line 71 1.9 72 1.2
Maintenance of central-line 75 1.8 75 1.1
Indications for removal of central-line 66 2.0 52 1.5
Hand hygiene done using alcohol based hand rubs (always/most of the times) 92 1.9 94 1.5
Respondent
Years working in ICU (mean) 8 0.3 16 0.3
Gender (females) (%) 55 2 44 1.5
Profession (doctors) (%) 59 2 70 1.4
Absolute numbers are not reported because percentages are weighted estimates
*Standard error
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the actual CLABSI rate in their unit. Our findings are
comparable to several other studies or surveys con-
ducted on CLABSI prevention practices in ICU’s at
local level [21–23]. A survey assessing implementation
of preventive CLABSI measures and monitoring of
compliance to these measures, identified that the use of
full body drape during CVC insertion was among the
measures less applied. Moreover, less than 50% of hos-
pitals included in this study reported monitoring
compliance to recommended measures [22]. Finally,
Furuya et al. identified that daily line checks and opti-
mal site selection were least commonly implemented.
In this study only a disappointing 38% of those that
monitored bundle implementation reported full com-
pliance, this aligns with our low reported numbers. The
availability of a bundle policy and monitoring of com-
pliance and a compliance of at least 95% were needed
to decrease CLABSI rates [23].
Table 3 CLABSI prevention: clinical practices during insertion and maintenance by income category, as reported by ICU doctors and
nurses in 2015
Middle income countries
(14 countries)
High income countries
(27 countries)
N = 836 N = 2,414
%* SE** %* SE**
Procedures at insertion
In my ICU, the following procedures were used during the last catheter insertion I did or assisted in…
Hand hygiene before central line insertion 97 0.7 98 0.3
Using mask, cap, sterile gloves and sterile gown 93 1.0 96 0.5
Using chlorhexidine >0.5% in alcohol for skin preparation 58 2.1 85 0.9
Using sterile drapes to cover patient from head to toes 51 2.1 82 0.9
Using antimicrobial ointment at insertion site (NR***) 14 1.4 9 0.9
Administering systemic antimicrobial prophylaxis for CLABSI prevention (NR***) 24 1.8 8 0.7
Four recommended practices and none of not recommended 23 1.7 62 1.4
Insertion site
Ultrasound guidance was used last time central line was inserted in the internal jugular vein (%yes) 50 2.1 79 1.1
In my ICU, the femoral vein is used always, or most of the time (NR***) 15 1.3 11 0.9
Procedures at maintenance
When I last accessed a central-line, I…
Disinfected central line hubs when accessing ports 84 1.5 82 1.0
Disinfected my hands before 87 1.4 88 0.9
Used gloves 59 2.1 84 1.4
Change of dressing (if not soiled, damped or loose)
Dry Dressing (sterile gauze)
every 2 days 20 1.7 15 1.0
more often (NR***) 31 1.9 24 1.2
less often (NR***) 34 2.0 29 1.1
Don’t know 15 1.5 32 1.4
Transparent Dressing
every 5-7 days 22 1.7 41 1.5
more often (NR***) 70 1.9 40 1.2
less often (NR***) 2 0.5 2 0.4
Don’t know 6 0.9 17 1.1
In my ICU, patients with a central line are assessed daily for the need or removal of it
(explicitly: with a note in clinical file, or a tick on a check list)
60 2.0 73 1.2
*Absolute numbers are not reported because percentages are weighted estimates
**Standard error
***Not recommended
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Strengths and limitations
The strengths of this study are the large number of re-
spondents, the proportion of nurses (40%) and the abil-
ity to provide country-specific results for a large number
of countries. However, our results are based on a non-
random sample of respondents, we have not been able
to compute a response rate, and we do not know the
number of ICUs as the online questionnaire did not
include questions allowing for the identification of the
ICU, in order to preserve the anonymity of the respon-
dents. In addition, given the dissemination strategy-
through international and national societies-some cat-
egories of ICU doctors and nurses are likely to be over-
represented. Members of these societies might be better
informed, and might have better prevention practices,
than non-respondents to the survey. Those working in
Table 4 CLABSI prevention: measurements by income category, as reported by ICU doctors and nurses in 2015
Measurements Middle income countries
(14 countries)
High income countries
(27 countries)
N = 836 N = 2414
%a SEb %a SEb
Measurement of compliance to recommendations at least one a year
Central line insertion 72 2.0 66 1.5
Daily assessment of a need for a central line 72 2.0 59 1.5
Disinfection practices when accessing the central line 73 2.0 59 1.5
Hand hygiene 81 2.1 73 1.5
“In my ICU, there is a written definition of CLABSI for data collection”
Yes 78 1.7 70 1.2
“In my ICU, we count and record, routinely…” (% saying “yes”)
CLABSI 73 1.8 81 0.9
Days since last CLABSI 39 2.0 57 1.4
Respondents reporting data (%)- for part or all of 2015
CLABSI Rate (either per central-line days, or per patient-days) 16 1.5 26 1.4
“Clinical staff in my ICU is aware of CLABSI-related data, and their trends” (% agree strongly/agree) 76 2.0 67 1.4
aAbsolute numbers are not reported because percentages are weighted estimates
bStandard Error
Table 5 Attitudes towards the implementation of a measurement system of infections in ICUs by income category, as reported by
ICU doctors and nurses in 2015
Middle income countries
(14 countries)
High income countries
(27 countries)
N = 836 N = 2414
Agree strongly/
agree
Disagree/disagree
strongly
Agree strongly/
agree
Disagree/disagree
strongly
%a SEb %a SEb %a SEb %a SEb
To what extent do you agree with the following comments
If you cannot measure it, you cannot improve it 81 2.0 3 0.7 80 1.5 9 0.8
Monitoring of CLABSI related measures stimulates quality
improvement
96 2.0 1 0.3 91 1.5 1 0.7
These data can be used against me 21 1.0 55 1.0 24 0.8 52 1.4
CLABSI-related data in my ICU (if any) are reliable 74 2.0 2 0.2 68 1.5 6 0.6
I am willing to implement, or support, a CLABSI data
collection system
92 2.0 1 0.1 88 1.5 1 0.1
Clinical diagnosis of CLABSI is difficult: this makes measurement
systems unreliable
40 1.9 24 1.0 27 1.2 44 1.4
There is a difference between a definition of CLABSI for reporting,
and a diagnosis of CLABSI for treatment
54 2.1 12 0.4 47 1.4 23 1.1
aAbsolute numbers are not reported because percentages are weighted estimates
bStandard Error
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ICUs where CLABSI prevention guidelines exist might
have been more motivated to participate in this survey.
Reported practices are likely to differ from actual prac-
tices and be biased towards what the respondent be-
lieved to be desirable. These selection and reporting
biases would lead to our results overestimating true
compliance with recommended practices.
We used SHEA guidelines, but these are not “global”
standards and some prevention measures recommended
in SHEA guidelines might be controversial such as
disinfection with chlorhexidine 0.5% in specific settings
[24]. However it was beyond the scope of this article to
assess the evidence supporting each recommendation.
Detailed information for each recommendation is given
in the country-specific file, so that the usefulness of this
information can be assessed against national or local
guidelines.
The grouping of our data in order to provide estimates
for “high income” and “middle income” countries was a
convenient way to aggregate the data, but given the het-
erogeneity of practices between countries these summary
estimates have limited meaning, and the most relevant
data can be found in the country-specific results pre-
sented in the Additional file 1.
We did not explore whether results differed between
nurses and doctors (this will be the subject of a subse-
quent research).
Interpretation
The large number of respondents, and the large propor-
tion of ICUs where CLABSI prevention guidelines are
available, likely reflect the interest and awareness of the
ICU community in the issue of CLABSI prevention. Se-
lection and reporting bias in our study lead to the over-
estimation of CLABSI prevention practices in ICU’s,
therefore weaknesses identified seem robust enough to
identify interventions for improvement. Priorities for im-
provement differ between countries; from encouraging
the use of chlorhexidine >0.5% in alcohol for skin prep-
aration and sterile drapes to covering patients from head
to toes, to discouraging the use of the femoral vein as
preferred insertion site. Improving knowledge of clinical
guidelines is far from sufficient to improve practices but
it is a prerequisite [25].
Availability and discussion of ICU data is also very im-
portant as it can serve to highlight opportunities and areas
for improvement. The majority of respondents agree that
monitoring of CLABSI-related measures stimulates qual-
ity improvement but very few actually knew their data. In
order for clinical staff to monitor trends over time and re-
port real time feed-back they should be educated in how
to generate reliable data through indicators that measure
compliance. A compromise needs to be found between
time-consuming data collection, and usefulness of data.
Simple measures promoted by hospital management can
be implemented to increase knowledge of CLABSI data at
ICU level, e.g. a panel with the number of days since last
ICU-acquired infection (including CLABSI) can be dis-
played on the wall and updated daily.
Conclusions
This international study shows that there is clear interest
and awareness in the ICU community for CLABSI preven-
tion in high and middle income countries, but implemen-
tation and adherence to existing guidelines on insertion
and maintenance of CL need to be reinforced at ICU level.
Areas for improvement in practices (clinical and measure-
ment) related to CLABSI prevention in ICUs have been
identified and include: full barrier precautions, reduction
of device exposure through daily assessment of CL, and
utilization of data to monitor progress in preventive ac-
tions. Priorities for improvement differ from country to
country. It would be advantageous to continue to address
factors that may be affecting the adoption and consistent
use of CLABSI prevention guidelines, as well as encour-
aging collaboration on ICU accountability by close moni-
toring of infection rates, giving feedback to staff, and
establishing a reliable data collection system.
Additional file
Additional file 1: Country Specific Results _xls. (XLS 214 kb)
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